A rare case report of iatrogenic Cushing syndrome caused by direct anti-hepatitis C virus therapy with sofosbuvir/velpatasvir

Sofosbuvir/velpatasvir (SOF/VEL) is a combination of direct-acting antivirals with pan-genotypic activity that is used to treat chronic hepatitis C virus infection. This was a fixed-dose regimen. SOF is a nucleotide nonstructural 5B polymerase inhibitor and VEL is an nonstructural 5A inhibitor. Side...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bo, Shang, Tianling, Huang, Jianjie, Tu, Zhixin, Wang, Yan, Han, Yujin, Wang, Yang, Wen, Xiaoyu, Jin, Qinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794295/
https://www.ncbi.nlm.nih.gov/pubmed/36595855
http://dx.doi.org/10.1097/MD.0000000000030294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794295/
https://www.ncbi.nlm.nih.gov/pubmed/36595855
http://dx.doi.org/10.1097/MD.0000000000030294

Ejemplares similares